Select your Country or Region

  • TargetMol | Compound LibraryArgentinaArgentina
  • TargetMol | Compound LibraryAustraliaAustralia
  • TargetMol | Compound LibraryAustriaAustria
  • TargetMol | Compound LibraryBelgiumBelgium
  • TargetMol | Compound LibraryBrazilBrazil
  • TargetMol | Compound LibraryBulgariaBulgaria
  • TargetMol | Compound LibraryCroatiaCroatia
  • TargetMol | Compound LibraryCyprusCyprus
  • TargetMol | Compound LibraryCzechCzech
  • TargetMol | Compound LibraryDenmarkDenmark
  • TargetMol | Compound LibraryEgyptEgypt
  • TargetMol | Compound LibraryEstoniaEstonia
  • TargetMol | Compound LibraryFinlandFinland
  • TargetMol | Compound LibraryFranceFrance
  • TargetMol | Compound LibraryGermanyGermany
  • TargetMol | Compound LibraryGreeceGreece
  • TargetMol | Compound LibraryHong KongHong Kong
  • TargetMol | Compound LibraryHungaryHungary
  • TargetMol | Compound LibraryIcelandIceland
  • TargetMol | Compound LibraryIndiaIndia
  • TargetMol | Compound LibraryIrelandIreland
  • TargetMol | Compound LibraryIsraelIsrael
  • TargetMol | Compound LibraryItalyItaly
  • TargetMol | Compound LibraryJapanJapan
  • TargetMol | Compound LibraryKoreaKorea
  • TargetMol | Compound LibraryLatviaLatvia
  • TargetMol | Compound LibraryLebanonLebanon
  • TargetMol | Compound LibraryMalaysiaMalaysia
  • TargetMol | Compound LibraryMaltaMalta
  • TargetMol | Compound LibraryMoroccoMorocco
  • TargetMol | Compound LibraryNetherlandsNetherlands
  • TargetMol | Compound LibraryNew ZealandNew Zealand
  • TargetMol | Compound LibraryNorwayNorway
  • TargetMol | Compound LibraryPolandPoland
  • TargetMol | Compound LibraryPortugalPortugal
  • TargetMol | Compound LibraryRomaniaRomania
  • TargetMol | Compound LibrarySingaporeSingapore
  • TargetMol | Compound LibrarySlovakiaSlovakia
  • TargetMol | Compound LibrarySloveniaSlovenia
  • TargetMol | Compound LibrarySpainSpain
  • TargetMol | Compound LibrarySwedenSweden
  • TargetMol | Compound LibrarySwitzerlandSwitzerland
  • TargetMol | Compound LibraryTaiwan,ChinaTaiwan,China
  • TargetMol | Compound LibraryThailandThailand
  • TargetMol | Compound LibraryTurkeyTurkey
  • TargetMol | Compound LibraryUnited KingdomUnited Kingdom
  • TargetMol | Compound LibraryUnited StatesUnited States
  • TargetMol | Compound LibraryOther CountriesOther Countries
Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty
Filter
Applied FilterClear all
TargetMol | Tags By Target
  • Calcium Channel
    (1)
  • Endogenous Metabolite
    (1)
  • PKA
    (2)
  • Others
    (19)
Filter
Search Result
Results for "

8-bromo-cyclic amp

" in TargetMol Product Catalog
  • Inhibitor Products
    21
    TargetMol | Activity
  • Dye Reagents
    1
    TargetMol | inventory
  • Natural Products
    1
    TargetMol | natural
8-bromo-Cyclic AMP
T3542423583-48-4
8-bromo-Cyclic AMP is a brominated derivative of cAMP that remains long-acting due to its resistance to degradation by cAMP phosphodiesterase. It can activate cAMP-dependent protein kinase, inhibiting growth, decreasing proliferation, increasing differentiation, and inducing apoptosis of cancer cells.
  • $140
35 days
Size
QTY
TargetMol | Inhibitor Sale
8-Bromo-cGMP sodium
T1406451116-01-9In house
8-Bromo-cGMP sodium is a PKG activator, a membrane-permeable analog of cGMP. 8-Bromo-cGMP sodium has pain-relieving and vasodilatory effects, significantly inhibits Ca2+ macroscopic currents, and inhibits high K+-stimulated insulin release.
  • $55
In Stock
Size
QTY
8-Bromo-cAMP sodium salt
T674776939-46-3
8-Bromo-cAMP sodium salt (8-Br-Camp sodium salt) is a long-acting derivative of cyclic AMP. It is an activator of cyclic AMP-dependent protein kinase(PKA), but resistant to degradation by cyclic AMP phosphodiesterase.
  • $41
In Stock
Size
QTY
TargetMol | Citations Cited
Cyclic di-AMP (sodium salt)
T35595
Cyclic di-AMP (c-di-AMP) is a second messenger produced by bacteria but not by mammals. Generated by a family of diadenylate cyclases, c-di-AMP can impact bacterial cell growth, cell wall homeostasis, pathogenicity, and other cellular functions. Bacteria-derived cyclic dinucleotides, including c-di-AMP, trigger the expression of interferon genes in mammalian cells.
  • $390
Backorder
Size
QTY
TargetMol | Inhibitor Sale
8-bromo NAD+ sodium
T837982022926-16-3
8-Bromo NAD+ serves as a prodrug for the cyclic ADP-ribose (cADPR) inhibitor, 8-bromo cADPR, undergoing conversion to its active form by the enzyme CD38. At a concentration of 1 mM, it effectively inhibits the rise in intracellular calcium levels and chemotaxis triggered by N-formyl-Met-Leu-Phe (fMLP) in mouse bone marrow-derived neutrophils. Furthermore, when applied at 100 µM, this compound reduces LPS-induced nitrite production and decreases the secretion of TNF-α and IL-2 in mouse primary microglial cells.
  • $473
35 days
Size
QTY
8-Bromo-3-methyl-1H-purine-2,6(3H,7H)-dione
T6562693703-24-3
8-Bromo-3-methyl-1H-purine-2,6(3H,7H)-dione is a useful organic compound for research related to life sciences. The catalog number is T65626 and the CAS number is 93703-24-3.
    7-10 days
    Inquiry
    8-Bromo-2’-deoxyadenosine
    TNU079314985-44-5
    8-Bromo-2'-deoxyadenosine is a 2'-Deoxynucleoside; Halo-nucleoside.
    • Inquiry Price
    7-10 days
    Size
    QTY
    Rp-8-bromo-Cyclic AMPS (sodium salt)
    T36677925456-59-3
    Rp-8-bromo-Cyclic AMPS (Rp-8-bromo-cAMPS) is a cell-permeable cAMP analog that combines an exocyclic sulfur substitution in the equatorial position of the cyclophosphate ring with a bromine substitution in the adenine base of cAMP. It acts as an antagonist of cAMP-dependent protein kinases (PKAs) and is resistant to hydrolysis by cyclic nucleotide phosphodiesterases. Rp-8-bromo-cAMPS more effectively antagonizes cAMP-dependent activation of purified PKA type I from rabbit muscle than PKA type II from bovine heart.
    • $438
    35 days
    Size
    QTY
    8-Bromo-9-(b-D-xylofuranosyl)guanine
    TNU03821212650-12-8
    8-Bromo-9-(b-D-xylofuranosyl)guanine is a Nucleoside Derivative - Xylo-nucleoside; 8-Modified purine nucleoside.
    • Inquiry Price
    7-10 days
    Size
    QTY
    8-bromo-Cyclic ADP-Ribose (sodium salt)
    T37803
    Cyclic ADP-ribose (cADP-ribose) is a calcium mobilizing nucleotide that is biosynthesized from NAD+ by cADP-ribose synthases, including CD38. cADP-Ribose appears to activate calcium channels in intracellular membranes, which in turn activate ryanodine receptors. 8-bromo-cADP-Ribose is a stable, cell-permeable analog that blocks calcium release evoked by cADP-ribose in sea urchin egg homogenates with an IC50 value of 1.7 μM. It is commonly used to investigate intracellular signaling through cADP-ribose in isolated cells and tissues.
    • $589
    Backorder
    Size
    QTY
    (R)-8-(Benzyloxy)-5-(2-bromo-1-hydroxyethyl)quinolin-2(1H)-one
    T66255530084-79-8
    (R)-8-(Benzyloxy)-5-(2-bromo-1-hydroxyethyl)quinolin-2(1H)-one is a useful organic compound for research related to life sciences. The catalog number is T66255 and the CAS number is 530084-79-8.
      7-10 days
      Inquiry
      8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione
      T66320853029-57-9
      8-Bromo-7-(but-2-yn-1-yl)-3-methyl-1-((4-methylquinazolin-2-yl)methyl)-1H-purine-2,6(3H,7H)-dione is a useful organic compound for research related to life sciences. The catalog number is T66320 and the CAS number is 853029-57-9.
        7-10 days
        Inquiry
        8-Bromo-ATP
        T3989123567-97-7
        8-Bromo-ATP (8-Bromoadenosine 5'-triphosphate) is a purinergic P2X receptor agonist and an ATP analogue. It exhibits cytotoxicity towards multiple myeloma cells, with an IC50 of 23.1 μM.
        • $970
        Backorder
        Size
        QTY
        Cyclic AMP
        TCO274560-92-4
        Cyclic AMP (cAMP) (Adenosine 3',5'-cyclophosphate) combined with vitamin C treatment of children with viral myocarditis has exact curative effect, and it can improve cardiac function of patients and improve immune function.
        • $48
        In Stock
        Size
        QTY
        8-Bromo-5’-O-(4-cyanobenzyl)-2’,3’-O-isopropylidene adenosine
        TNU07461134156-53-8
        5’-modified nucleoside; halo-nucleoside
        • Inquiry Price
        7-10 days
        Size
        QTY
        8-Bromo-AMP
        T3989023567-96-6
        8-Bromo-AMP, also known as 8-Bromoadenosine 5'-monophosphate, is a membrane permeable cAMP analogue. It enhances cardiac recovery from ischemia and reperfusion by elevating ATP, ADP, and total adenine nucleotide concentrations.
          7-10 days
          Inquiry
          8-Bromo-3’-deoxy-3’-fluoroguanosine
          TNU0448847649-50-7
          Nucleoside Derivatives - 3’-Modified nucleosides; 8-Modified nucleosides; Fluoro-modified nucleosides
          • Inquiry Price
          7-10 days
          Size
          QTY
          8-Aza-7-bromo-7-deazaguanosine
          TNU027596555-37-2
          8-Aza-7-bromo-7-deazaguanosine is a Nucleoside Derivative - 7-Deaza-8-aza-purine nucleoside; Halo-nucleoside; Scaffold and Template.
          • Inquiry Price
          7-10 days
          Size
          QTY
          8-Bromo-2’-deoxyguanosine
          TNU079213389-03-2
          8-Bromo-2'-deoxyguanosine is a 2'-Deoxynucleoside; Halo-nucleoside.
          • Inquiry Price
          7-10 days
          Size
          QTY
          8-Bromo-3’-deoxyguanosine
          TNU0445847649-68-7
          Nucleoside Derivatives - 3’-Modified nucleosides; 8-Modified nucleosides; Halo-nucleosides;3’-Deoxy nucleosides
          • Inquiry Price
          7-10 days
          Size
          QTY
          8-CPT-Cyclic AMP (sodium salt)
          T2170593882-12-3
          8-CPT-Cyclic AMP (8-CPT-cAMP) sodium functions dually as a selective activator of cyclic AMP-dependent protein kinase (PKA) and as a potent inhibitor of the cyclic GMP-specific phosphodiesterase (PDE VA), demonstrating an inhibitory concentration (IC 50) of 0.9 μM. Additionally, this compound inhibits PDE III and PDE IV, while significantly activating Epac, showcasing its diverse pharmacological activities [1] [2].
            7-10 days
            Inquiry